<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03423329</url>
  </required_header>
  <id_info>
    <org_study_id>FDASU-REC R 071607</org_study_id>
    <nct_id>NCT03423329</nct_id>
  </id_info>
  <brief_title>Effectiveness of Buccal Infiltration During Vital Pulpotomy After Administering Two Analgesic Premedications</brief_title>
  <official_title>Effect of Preoperative Oral Administration of Ibuprofen and Acetaminophen on the Anesthetic Efficacy of Buccal Infiltration During Vital Pulpotomy of Mandibular Primary Molars: A Prospective, Double-blinded, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Randomized study was designed to assess and compare the effect of two analgesic
      premedications (Ibuprofen BP 100 mg/5 ml and Paracetamol 200 mg/5ml.) on the anesthetic
      efficacy of buccal infiltration in vital pulpotomy of primary mandibular molars in children .
      A multivitamin with the same color as the twp tested medications will be administered to
      children in the control group. Parents of eligible children will be informed about the nature
      of the procedure, the purpose of the study, any possible discomfort or risks and a signed
      informed consent will be obtained from them prior to enrollment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 60 healthy children will be recruited from the outpatient clinic of the Pediatric
      Dentistry and Dental Public Health Department, Faculty of Dentistry, Ain Shams University.

      Inclusion Criteria include: age group 7-9 years Without systemic or mental disorders. Who
      could be categorized as cooperative according to Wright's classification for child behavior
      Ability of child to understand the use of pain scales; Having at least one lower second
      primary molar with deep caries indicated for pulpotomy; Absence of any periapical or
      furcation radiolucency on radiographs, Absence of any signs of internal or external
      resorption on radiographs, A vital coronal pulp on access opening.

      . Patients who had taken analgesics within 12 hours before administration of the study drugs
      or those having active pain, pulpitis or abscess related to the designated mandibular molar
      will not be included.

      To ensure randomization and allocation concealment, children will be randomly assigned to the
      three groups using computer-generated numbers.

      One operator will do pulpotomy for all participants and to ensure blinding, another author (
      will give the premedication to children.Pain during pulpotomy will be assessed using Wong
      Baker FACES pain assessment tool.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 20, 2018</start_date>
  <completion_date type="Actual">April 25, 2018</completion_date>
  <primary_completion_date type="Actual">April 25, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain/discomfort felt during vital pulpotomy of mandibular second primary molars</measure>
    <time_frame>75 minutes after drug administration</time_frame>
    <description>Using Wong Baker FACES pain assessment tool Children will be asked to rate any pain felt during coronal access</description>
  </primary_outcome>
  <other_outcome>
    <measure>Pain /discomfort in carious mandibular primary second molar</measure>
    <time_frame>Just before drug administration</time_frame>
    <description>Using Wong Baker FACES pain assessment tool Children will be asked to rate any pain felt in designated molar before treatment</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention:Drug: Brufen &amp; Placebo
Brufen syrup 10 ml, once, 1 hour before local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Drug: Cital and Placebo
Cital Syrup 10 ml, once 1 hour before Local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intervention: Drug: Placebo
Other names:
(Placebo for Brufen) (Placebo for Cital)
Sansovit Iron Multivitamin syrup, an orange-coloured, orange-flavoured</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Brufen</intervention_name>
    <description>Brufen Syrup</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Advil</other_name>
    <other_name>Nurfen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cital</intervention_name>
    <description>Cital Cyrup</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Paramol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo for Brufen</intervention_name>
    <description>Sansovit Syrup</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Placebo for Cital</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age group 7-9 years

          2. Patients medically free.

          3. Patients who can be categorized as cooperative or potentially cooperative according to
             Wright's classification for child behavior

          4. Patients able to understand the use of pain scales;

          5. Having at least one lower second primary molar with deep caries indicated for
             pulpotomy;

          6. A vital coronal pulp on access opening of designated molar.

        Exclusion Criteria:

          1. Patients with allergic reactions, sensitivity, or contraindications to any tested
             drugs

          2. Patients who had taken analgesics within 12 hours before administration of the study
             drugs

          3. Patients having active pain, pulpitis or abscess related to the designated mandibular
             molar.

          4. Children with special health care needs or any systemic problems

          5. Presence of periapical or furcation radiolucency on radiographs in relation to
             designated molar

          6. Presence of of any signs of internal or external resorption on radiographs in relation
             to designated molar
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>9 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reham Abou El Fadl, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <state>Other</state>
        <zip>11341</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>December 28, 2017</study_first_submitted>
  <study_first_submitted_qc>February 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2018</study_first_posted>
  <last_update_submitted>November 13, 2018</last_update_submitted>
  <last_update_submitted_qc>November 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Reham Abou El Fadl</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Within one month after study completion</ipd_time_frame>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT03423329/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

